The ADP-ribosyltransferase activity of pertussis toxin resides within the S-1 subunit of the toxin. Deletion mapping of a recombinant S-1 subunit produced in Escherichia coli showed that amino acids 2 through 180 are required for ADP-ribosylation of G; protein. Mutants of the S-1 subunit which lacked either amino acids 2 through 22 or amino acids 153 through 180 failed to express enzyme activity, implicating a functional or structural role for these residues in catalysis. The catalytic carboxy-terminal S-1 deletion, C-180, was found to be more soluble than the recombinant S-1 subunit, making it a useful construct for future structure-function studies on enzyme catalysis. Four independent single-amino-acid substitutions which decreased ADP-ribosyltransferase activity were constructed in the recombinant S-1 subunit. Substitution of Asp-11 by Ser, Arg-13 by Leu, or Trp-26 by Ile decreased enzyme activity to below detectable levels (less than 1.0% of that of the recombinant S-1 subunit). The Glu-139-to-Ser substitution reduced ADP-ribosyltransferase activity to 15% of that of the recombinant S-1 subunit. Both the oxidized and reduced forms of the recombinant S-1 subunit and recombinant S-1 subunits containing single-amino-acid substitutions were degraded through identical immunoreactive tryptic peptides, suggesting that the conformations of the mutants are similar to that of the recombinant S-1 subunit. Identification of noncatalytic forms of the S-1 subunit of pertussis toxin which have conserved protein structure is an initial step in the generation of a recombinant noncatalytic form of pertussis toxin which may be tested as a candidate for an acellular vaccine against Bordetella pertussis.
Pertussis toxin (PT; molecular weight, 105,060) is composed of six noncovalently bound subunits designated S-1 through S-5. There is one copy of each subunit except S-4, which is present in two copies. The S-1 subunit contains 235 amino acids (18) and catalyzes the covalent transfer of the ADP-ribose portion of NAD to G1 protein, the negative regulatory component of the adenylate cyclase complex (21) .
ADP-ribosylation of Gi protein potentiates the adenylate cyclase response to stimulatory cyclase modifiers and attenuates the adenylate cyclase response to inhibitory cyclase modifiers (8) . The remaining five subunits (S-2 through S-5) make up a pentamer which is responsible for delivering the S-1 subunit to the Gi protein (21) .
PT and the filamentous hemagglutinin are two virulence factors produced by Bordetella pertussis (24) which also act as immunogens to stimulate production of protective antibodies against the bacterium. Immunization of mice with purified preparations of either PT or filamentous hemagglutinin produces a protective immune response to aerosol infection by B. pertussis (19) . An acellular vaccine composed of an extract from B. pertussis containing both PT and filamentous hemagglutinin has been developed (20) .
The recent cloning of the PT operon into Escherichia coli has allowed another approach to the development of an acellular pertussis vaccine, using a recombinant nontoxic form of PT as an immunogen. Locht and Keith (12) and Nicosia et al. (18) have cloned the entire PT operon in E. coli and sequenced it. Genes encoding the subunits of PT have been expressed in E. coli under the regulation of several E. coli promoters (3, 4, 11, 17) . Locht et al. (11) recently produced a catalytically active deletion mutant of the S-1 subunit which contained only amino acids 2 through 187. In protein composed of the first five amino acids of P-galactosidase and seven amino acids from the pUC18 polylinker followed by amino acids 2 through 235 of the S-1 subunit or the indicated derivative of pUCS-1 was digested with restriction enzymes to produce a series of deletions within the DNA encoding the amino or carboxy terminus of the S-1 subunit (Fig. 1) .
Amino-terminal deletions of the S-1 subunit. (i) Construc mid was ligated (pN-23) and transformed into E. coli. pN-23 encoded a fusion protein composed of the first five amino acids of P-galactosidase and three amino acids from the pUC8 polylinker followed by amino acids 23 through 235 of the S-1 subunit.
(ii) Construction of pN-78. DNA from pUCSau/Sal (3) which contained DNA encoding a fusion protein composed of the first five amino acids of 3-galactosidase and seven amino acids from the pUC18 polylinker followed by amino acids 2 through 109 of the S-1 subunit was sequentially digested with SmaI and NaeI. The digested plasmid was ligated (pUCS/S-N78) and transformed into E. coli. pUCS/ S-N78 contained DNA encoding a fusion protein composed of the first five amino acids of P-galactosidase and six amino acids of the pUC18 polylinker followed by amino acids 78 through 109 of the S-1 subunit. A SalI-HindIll DNA fragment encoding amino acids 109 through 235 of the S-1 subunit was ligated into the same sites of pUCS/S-N78, yielding pN-78. pN-78 encoded a fusion protein composed of the first five amino acids of P-galactosidase and six amino acids from the pUC18 polylinker followed by amino acids 78 through 235 of the S-1 subunit.
(iii) Construction of pN-109. DNA from pUCS-1 was sequentially digested with SmaI and HincII. The digested plasmid was ligated (pN-109) and transformed into E. coli. pN-109 encoded a fusion protein composed of the first five amino acids of 3-galactosidase and six amino acids from the pUC18 polylinker followed by amino acids 109 through 235 of the S-1 subunit.
Carboxy-terminal deletions of the S-1 subunit. (i) Construction of pC-180. DNA from pUCS-lterm was sequentially digested with NruI and EcoRV. The restricted plasmid was ligated (pC-180) and transformed into E. coli. pC-180 contained DNA encoding a fusion protein composed of the first five amino acids of P-galactosidase and seven amino acids from the pUC18 polylinker followed by amino acids 2 through 180 of the S-1 subunit.
(ii) Construction of pC-152. An EcoRV restriction site was introduced into pUCS-1 within the DNA encoding amino acids 151 and 152 of the S-1 subunit. The restriction site was constructed by oligonucleotide-directed mutagenesis (as described below) using the synthetic oligonucleotide 5 amino acids from the pUC18 polylinker followed by amino acids 2 through 152 of the S-1 subunit.
(iii) Construction of pC-123. DNA from pUCS-lterm was sequentially digested with BalI and EcoRV. The restricted plasmid was ligated (pC-123) and transformed into E. coli. pC-123 contained DNA encoding a fusion protein composed of the first five amino acids of P-galactosidase and seven amino acids from the pUC18 polylinker followed by amino acids 2 through 123 of the S-1 subunit.
(iv) Construction of pC-108. DNA from pUCS-lterm was sequentially digested with HinclI and EcoRV. The restricted plasmid was ligated (pC-108) and transformed into E. coli. pC-108 contained DNA encoding a fusion protein composed of the first five amino acids of ,-galactosidase and seven amino acids from the pUC18 polylinker followed by amino acids 2 through 108 of the S-1 subunit.
Single-amino-acid substitutions within the S-1 structural gene. A BamHI-HindIII fragment from pUCS-1 was cloned into M13mp18, yielding M13mpl8::S1. Oligonucleotide-directed mutagenesis was performed by the double-primer technique, as previously described (23) or as described by Eckstein and co-workers (22) , with an in vitro mutagenesis system (Amersham Corp.). Oligonucleotides used to generate the four single-amino-acid substitutions within the S-1 subunit are shown in Table 1 . Substitutions were identified by primer hybridization, with the oligonucleotide which generated the mutation as a probe. The mutation was confirmed by dideoxy sequencing of phage DNA. Restriction fragments containing the desired base substitution from replicative-form phage M13 were ligated into the pUC expression vector and transformed into E. coli.
Genetic manipulations. Plasmids for restriction endonuclease digestions and M13 phage for oligonucleotide-directed mutagenesis were isolated from E. coli JM103 or TG1 (Amersham Corp.). XbaI digestions were performed on plasmids isolated from GM119, a Dam-Dcm-strain of E. coli (New England BioLabs). General techniques for the manipulation of plasmids were performed as described in the Cold Spring Harbor molecular cloning manual (13) . M13 and E. coli JM103 were manipulated as described by Messing (14) .
Preparation of cell extracts. Plasmids containing deletions or single-amino-acid substitutions within the S-1 gene were transformed into LC137, a protease-deficient strain of E. coli (3) . Overnight cultures of LC137 were diluted 1/100 in L broth containing 100 ,g of ampicillin and 12.5 ,ug of tetracycline per ml and were shaken for 6 h at 30°C. Cells were concentrated by centrifugation at 5,000 x g for 6 min at 4°C, suspended in 1.0 ml of 10 mM Tris hydrochloride (pH 8.0) containing 2 p.g of phenylmethylsulfonyl fluoride per ml, and (Table 2) . Cell extracts were added last to start the reaction. After 1 h at 37°C, erythrocyte membranes were concentrated by centrifugation at 13,800 x g for 15 min, suspended in SDS-PAGE sample buffer containing ,B-mercaptoethanol, and subjected to 12.5% SDS-PAGE. ADP-ribosylated Gi protein was identified in the gel matrix by autoradiography. Exposure times were adjusted to allow the determination of a range of activity in constant proportion to the densitometric signal.
Optimal ADP-ribosylation of the Gi protein by the recombinant S-1 subunit required 20.0 mM dithiothreitol and 2.0 mM ATP. Dithiothreitol was required for the expression of enzyme activity, as described by others (21) , whereas the addition of ATP reduced the rate of non-S-1-mediated radiolabeling of an erythrocyte protein which migrated slightly faster than Gi protein in the SDS-polyacrylamide gels. Under the assay conditions, ADP-ribosylation of Gi protein was proportional to the amount of S-1 fusion protein in the reaction mixture.
Immunoblotting. Cell extracts were subjected to 13.5% SDS-PAGE in the presence of 3-mercaptoethanol. Proteins in the gel matrix were transferred electrophoretically to nitrocellulose and then probed with 125I-labeled anti-PT antibody (the gift of J. L. Cowell and C. R. Manclark, Bureau of Biologics, Food and Drug Administration, Bethesda, Md.). The nitrocellulose was then washed, and immunoreactive proteins were identified by autoradiography (23) . Exposure times were adjusted to allow the determination of a range of immunoreactive material in constant proportion to the densitometric signal. .0 mM dithiothreitol (added in specific experiments), 5 to 7 ,ug of urea-soluble extract, and the indicated amount of trypsin. After a 1-h incubation at 37°C, 1 ,ug of trypsin inhibitor was added, which was followed by SDS sample buffer containing P-mercaptoethanol, and the reaction mixture was subjected to 13.5% SDS-PAGE. Immunoreactive peptides were identified by immunoblotting.
RESULTS
Deletion mapping of the S-1 subunit. (i) Expression of deletion mutants of the S-1 structural gene in E. coli LC137. Three amino-terminal deletions (pN-23, pN-78, and pN-109) and three carboxy-terminal deletions (pC-108, pC-123, and pC-180) of the recombinant S-1 subunit were initially constructed (Fig. 1) . Gene products were named after the recombinant plasmid from which they were expressed; e.g., plasmid pN-23 produces the gene product N-23. Ureasoluble extracts from cells containing deletion plasmids possessed a single immunoreactive peptide when they were probed with anti-PT antibody (Fig. 2a) . The immunoreactive peptides migrated in SDS-polyacrylamide gels with apparent molecular weights corresponding to the expected size of the truncated S-1 subunit. Immunoreactive peptides have been quantified in terms of S-1 equivalent (Tables 2 and 3) relative to a known amount of authentic S-1 subunit. These values do not represent absolute values, since the absolute quantification of truncated or modified peptide is unreliable when polyclonal antibody is used. Measurement of the enzymatic activity in the urea-soluble extracts from the six recombinant deletion plasmids revealed that only C-180 expressed ADPribosyltransferase activity (activities of selected truncated proteins are shown below), indicating that amino acids 181 through 235 are not required for catalysis. Extracts from cells containing pN-23 or pC-123 did not express ADPribosyltransferase activity, which showed that one or more amino acids between 2 and 22 and between 123 and 180 are required for enzyme activity. A fourth carboxy-terminal deletion of the S-1 subunit, designated pC-152, was then constructed. C-152 was intermediate in size compared with the noncatalytic C-123 and the catalytic C-180 peptides. Urea-soluble extracts from cells containing pC-152 possessed a single immunoreactive peptide when they were probed with anti-PT antibody that migrated with an apparent molecular weight appropriate to the generated deletion (Fig.  2b) .
(ii) Recovery of truncated variants of the S-1 subunit from E. coli cell extracts. Like the S-1 fusion protein, essentially all of the N-23 and C-152 peptides were present in the particulate fraction of cells disrupted by sonication. In contrast, about 60% of C-180 was found in the soluble fraction of sonically disrupted cells (Fig. 3) . As observed with the recombinant S-1 subunit (3), N-23, C-152, and the fraction of C-180 that was present in the particulate fraction of sonicated cells could be converted to a soluble form by incubation in 7 M urea followed by dialysis.
(iii) Enzyme activities of truncated variants of the S-1 subunit from E. coli cell extracts. The recombinant S-1 subunit and the C-180 peptide possessed ADP-ribosyltransferase activity (Table 2) . Activity was detected in the ureasoluble extracts of the particulate cellular fractions as well as in the soluble cellular fractions. Thus, the S-1 fusion protein and the C-180 peptide found in the particulate fraction could refold to a soluble catalytic form after denaturation in urea. ADP-ribosyltransferase activity was not detected in either the soluble cellular fraction or the urea-soluble extracts of the particulate cellular fractions from cells containing either pN-23 or pC-152 ( not shown). Together, these data show that one or more amino acids between 2 and 22 and between 153 and 180 of the S-1 subunit are required for ADP-ribosyltransferase activity.
Single-amino-acid substitutions in the S-1 subunit. Four independent single-amino-acid substitutions were introduced between amino acids 2 and 180 of the S-1 subunit. Two amino acid substitutions were produced at the amino terminus of the S-1 subunit, changing Asp-11 to Ser (S-iS11) and Arg-13 to Leu (S-1L13). The single tryptophan within the catalytic region of the S-1 subunit, Trp-26, was changed to Ile (S-1126), and Glu-139 was changed to Ser (S-1S139). The rationale for choosing these residues for mutagenesis is discussed below.
(i) Expression of peptides. Similar to the recombinant S-1 subunit, essentially all of the S-1 subunits with single-aminoacid substitutions were present in the particulate fraction of sonically disrupted cells and were solubilized by incubation in 7 M urea followed by dialysis. Urea-soluble extracts from cells containing pUCS-IS11, pUCS-IL13, pUCS-1126, or pUCS-1S139 possessed a single immunoreactive protein which comigrated in SDS-polyacrylamide gels with the recombinant S-1 subunit (Fig. 4) . Equivalent amounts of protein from urea-soluble extracts of cells containing plasmids encoding for S-1 subunits with single-amino-acid substitutions possessed between 0.7 and 1.2 mol of immunoreactive S-1 equivalent relative to urea-soluble extracts from cells containing pUCS-1 (Table 3) .
(ii) substitutions were introduced into pC-180, which encodes a soluble and catalytically active C-180 peptide. Soluble extracts from cells containing pC-180S11, pC-180L13, or pC-180126 did not possess detectable amounts of ADP-ribosyltransferase activity (results not shown).
(iii) Trypsin degradation of peptides. To obtain a preliminary evaluation of the effects that the Sl1, L13, 126, and S139 substitutions had on protein structure, the recombinant S-1 subunit and S-1 subunits with single-amino-acid substitutions were subjected to degradation by trypsin. Both the initial cleavage and the subsequent generation of tryptic peptides of the oxidized and reduced forms of the S-1 subunits were determined. Cleavage of the oxidized and reduced forms of the S-1 subunits required similar amounts of trypsin. The oxidized recombinant S-1 subunit, S-lS11, S-1L13, S-1126, and S-1S139 were all degraded to an immunoreactive tryptic peptide with an apparent molecular weight of 22,500 (results not shown). Trypsin degradation of the
ADP-ribosyltransferase activity of the recombinant S-1 subunit and S-1 subunits with single-amino-acid substitutions in urea-soluble extracts of E. coli LC137. Protein (5 pg) from a urea-soluble extract of E. coli LC137 was assayed for ADP-ribosyltransferase activity as described in Materials and Methods. Lanes: A, no extract; B, 0.4 ,ug of authentic PT without extract; C, pUCS-1; D, pUCS-1S11; E, pUCS-1L13; F, pUCS-1126; G, pUCS-1S139.
The erythrocyte cell membranes in the reaction mixture were subjected to 12.5% SDS-PAGE in ,-mercaptoethanol. An autoradiogram of the gel is shown. The size of the protein is given in kilodaltons on the left. with the addition of 1.0 jig of trypsin inhibitor, and reaction mixtures were subjected to 13.5% SDS-PAGE in the presence of P-mercaptoethanol. Proteins in the gel matrix were transferred to nitrocellulose. An autoradiogram of the nitrocellulose which was probed with '25N-labeled anti-PT antibody is shown.
reduced S-1 equivalents is shown in Fig. 6 . In the presence of 20.0 mM dithiothreitol, all S-1 equivalents were sequentially degraded through three immunoreactive peptides with apparent molecular weights of 26,000, 23,500, and 22,500. The appearance of similar sequential tryptic peptides suggested that S-1 equivalents were degraded through similar proteolytic cascades. Tryptic cleavage of the oxidized and reduced forms of the recombinant S-1 subunit was not influenced by the addition of 2 mM NAD (results not shown). DISCUSSION A catalytic peptide of the S-1 subunit of PT composed of amino acids 2 through 180 was identified. Deletion mapping also showed that one or more amino acid residues between 2 and 22 and between 153 and 180 of the S-1 subunit are required for enzyme activity. Locht et al. (11) have also constructed a carboxy-terminal deletion peptide of the S-1 subunit which possesses ADP-ribosyltransferase activity.
The smallest amino-terminal deletion of the S-1 subunit generated (N-23) lacked the first 22 amino-terminal residues of the S-1 subunit. Like the S-1 fusion protein, essentially all of N-23 was present in the particulate fraction of sonically disrupted cells and was solubilized upon incubation in urea followed by dialysis. The lack of detectable ADP-ribosyltransferase activity by the N-23 peptide implicated a catalytic role for one or more amino acids between 2 and 22. The shared amino acid homology at the amino termini of the S-1 subunit of PT, cholera toxin (CT), and the heat-labile enterotoxin ofE. coli (LT) (12, 18) suggests that the amino-terminal residues of CT and LT are also involved in the expression of ADP-ribosyltransferase activity. While the C-152 peptide failed to express detectable amounts of ADP-ribosyltransferase activity, the C-180 peptide was catalytic, implicating a catalytic role for one or more amino acids between 153 and 180.
The lack of detectable enzyme activity in either N-23 or C-152 could be explained if (i) components of the NAD-or Gi-protein-binding sites are found between amino acids 2 and 22 or 153 and 180; (ii) certain amino acids between residues 2 and 22 or 153 and 180 are not within a binding site but rather are residues which permit proper alignment of the NAD-and Ga-protein-binding sites; (iii) the urea-solubilized peptide possessed the required components for catalysis but did not refold properly after solubilization in urea; or (iv) enzyme activity of the peptides was below the detectable limits of the assay. The abilities of the native S-1 subunit of PT (21) , the recombinant S-1 subunit, and the C-180 peptide to refold properly after denaturation in urea suggest that improper protein refolding is not responsible for the lack of detectable enzyme activity. One goal is to purify amounts of the N-23 and C-152 peptides sufficient to determine whether either peptide possesses NAD-binding capacity and NAD glycohydrolase activity.
The physical properties of the carboxy-terminal deletions of the S-1 subunit also varied with the length of the peptide. Like the recombinant S-1 subunit, the C-152 peptide, which lacked the 83 carboxy-terminal amino acids of the S-1 subunit, was present in the particulate fraction of cells disrupted by sonication, while about 60% of the C-180 peptide, which lacked the 55 carboxy-terminal amino acids of the S-1 subunit, was soluble in cells disrupted by sonication. Although we are unable to presently define the mechanism of this differential solubility, the soluble and catalytic C-180 peptide will be a useful construct for studies on the catalytic properties of S-1 subunit.
We have identified four single-amino-acid substitutions within the catalytic region of the S-1 subunit, each of which decreased ADP-ribosyltransferase activity. Future studies will determine whether these amino acids are involved as functional residues or modify activity via an allosteric mechanism. Strategies for choosing these residues for mutagenesis follow.
S-1S11 and S-1L13. Two observations prompted the targeting of Asp-11 and Arg-13 of the S-1 subunit for mutagenesis. Asp-11 and Arg-13 are located within the amino termi-VOL. 56, 1988 on August 14, 2017 by guest http://iai.asm.org/ Downloaded from nus of the S-1 subunit, which we showed by deletion mapping to be required for expression of enzyme activity, and both are within a string of eight amino acids of which seven were homologous to those of CT and LT (12, 18) . The specific substitutions, Asp-li to Ser and Arg-13 to Leu, were made to eliminate the ionic nature of the residue but retain some of the spatial composition of the R group. The fact that either the Asp-11-to-Ser or the Arg-13-to-Leu substitution reduces the ADP-ribosyltransferase activity in the S-1 subunit to below detectable levels implicates a catalytic role for these residues in CT and'LT as well as in PT.
S-1I26. Trp-26, the only tryptophan residue within the catalytic region of the S-1 subunit, was chosen for mutagenesis because tryptophan residues have been implicated in the binding of NAD to diphtheria toxin (DT) and Pseudomonas exotoxin A (Exo A), two other ADP-ribosyltransferase exotoxins. Michel and Dirkx (15) showed that NAD binding to fragment A of DT quenches the intrinsic tryptophan fluorescence of the peptide, while X-ray crystallographic studies on Exo A (1; S. F. Carroll, personal communication) showed that Trp-466 lies within the NAD-binding site of the protein. The amino acid substitution that changed Trp-26 to Ile was made with an essentially irreversible three-base substitution (TGG--ATC). One goal of our future studies is to determine whether the lack of detectable ADP-ribosyltransferase activity in S-1126 is due to the loss of the specific conformation of the tryptophan R group or to its more generally aromatic nature.
S-1S139. The decision to mutagenize Glu-139 was made with the goal in mind of identifying a glutamic acid residue within the S-1 subunit which would be analogous to Glu-148 of DT and Glu-553 of Exo A. Carroll et al. (5, 6) photoaffinity cross-linked the nicotinamide portion of NAD to Glu-148 of DT and Glu-553 of Exo A, implicating a functional role for each glutamic acid in the ADP-ribosyltransferase reaction. In preliminary experiments, NAD has been photoaffinity cross-linked to the S-1 subunit of PT, although at a lower molar efficiency than that obtained with either DT or Exo A (J. T. Barbieri and R. J. Collier, unpublished results). When analysis of primary amino acid sequences failed to align a specific glutamic acid in the S-1 subunit of PT with Glu-148 of DT, we considered the possibility that the amino acids surrounding analogous glutamic acids might be quite different, reflecting NAD-binding affinities of DT (Kd = 8 ,uM [7] ) and PT (Kd = 2.5 mM [9] ). We (J. T. Barbieri and S. F. Carroll) therefore searched for glutamic acids homologous between the S-1 subunit of PT and CT, which possesses a similar binding constant for NAD (16) . The algorithm FASTP (10) identified an amino acid alignment between the S-1 subunit of PT and CT comprising amino acids 7 through 150 of the S-1 subunit and 5 through 147 of CT. Within this amino acid overlap, there was only one glutamic acid alignment, Glu-139 of the S-1 subunit and Glu-137 of CT. Thus, Glu-139 of the S-1 subunit was targeted for mutagenesis. The Glu-139-to-Ser substitution was made to eliminate the ionic R group with minimal perturbation of steric conformation by using an essentially irreversible three-base change (GAA to TCC). S-iS139 possessed i5% of the ADP-ribosyltransferase activity of the recombinant S-1 subunit, while the analogous substitution in DT, Glu-148 to Ser, reduced ADPribosyltransferase activity by more than 2 orders of magnitude' (2) . Should Glu-139 of the S-1 subunit and Glu-148 of DT prove to perform similar functions in enzyme catalysis, the differential effect of the Ser substitutions may reflect differences in the NAD-binding affinities of the two toxins.
Conformational changes in the S-1 subunit upon introduction of single-amino-acid substitutions were analyzed by tryptic degradation. The goal was to obtain a preliminary evaluation of protein conformation, allowing identification of amino acid substitutions within the S-1 subunit which reduced enzymatic activity but conserved protein structure. These mutants could then be purified and subjected to detailed structure-function analysis. Tryptic digestion showed that both the oxidized and reduced forms of the recombinant S-1 subunit and S-1 subunits with single-aminoacid substitutions were degraded sequentially through immunoreactive tryptic peptides with identical apparent molecular weights. Single-amino-acid substitutions did not produce detectable alterations in the accessibility of tryptic sites or introduce additional trypsin-sensitive sites. Together, these results suggest that the individual amino acid substitutions introduced into the recombinant S-1 subunit did not produce gross conformational alterations in protein structure. Identification of mutations within the S-1 subunit which render the protein noncatalytic but retain protein conformation is the initial step in the construction of a recombinant noncatalytic form of PT which may be tested for use as an acellular vaccine.
